Most Recent
Failed NULIS class action can’t duck costs pending appeal
The lead applicant in a failed class action against ex-NAB super trustee NULIS Nominees has lost his bid to stay a costs order of some $12.5 million pending an appeal.
Fortrend lodges another appeal in spat with Shaw & Partners duo
Fortrend Securites is challenging a judge's ruling that it owes $580,000 in penalties and compensation for withholding the bonuses of two departing advisors, its second appeal in their bitter dispute.
IP Australia bursts Pepsi’s bubble, says patent claims obvious
A German bottling machine manufacturer has successfully opposed PepsiCo’s patent application for a filling system, after arguing the claims were obvious.
Cadbury wins challenge to ‘Crunchiez’ trade mark
Cadbury has successfully opposed a bid to register 'Crunchiez Surprize' as a trade mark, with a delegate finding the mark was deceptively similar to the mark for UK confectionery giant's  popular Crunchie chocolate bar. 
Construction PRO
No ‘screaming urgency’ in legal challenge to Woodside’s North Shelf extension, court told
The environment minister has argued there is no “screaming urgency” in hearing a traditional custodian’s legal challenge to Woodside’s bid to extend its North West Shelf gas project by 40 years. 
Construction PRO
Roberts Co sued for failing to pay $3.2M claim submitted two hours late
A contractor who worked on the Westmead Children's Hospital is seeking orders compelling Roberts Co to make a $3.2 million progress payment, arguing service past business hours on Friday was still Friday service. 
Mayne Pharma to challenge termination of $672M takeover in court
Mayne Pharma has said it will file a court challenge to the validity of US drug maker Cosette Pharmaceuticals' purported termination of a $672 million takeover offer.
Philips accused of knowing supply of dangerous CPAP machines
The Therapeutic Goods Administration has launched legal action against Philips Electronics for allegedly supplying CPAP and BiPAP devices, used to assist individuals with sleep apnea, which it knew posed risks to users.